TrialInternational journal of cancer2026
Penpulimab and Gemcitabine With or Without Anlotinib in Metastatic Nasopharyngeal Carcinoma: A Randomized, Open-Label, Multicenter Phase 2 Study.
Shuang Huang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.